Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma? (Q33907142)

29 July 2017

Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma? (English)

1 reference

alpha-1-antitrypsin deficiency

29 July 2017

0 references

1 reference

1 reference

Zhou H

1

1 reference

29 July 2017

Ortiz-Pallardó ME

series ordinal

2

1 reference

29 July 2017

Ko Y

series ordinal

3

1 reference

29 July 2017

Fischer HP

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

29 July 2017

1 reference

29 July 2017

88

1 reference

29 July 2017

2668-2676

1 reference

29 July 2017

12

1 reference

Molecular basis, clinical consequences and diagnosis of alpha-1 antitrypsin deficiency

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Review: alpha 1-antitrypsin deficiency associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Lack of increase in heterozygous α1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Liver carcinoma in PiZ alpha-1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Fixed archival tissue. Purify DNA and primers for good PCR yield!

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Alpha1 Antitrypsin Liver Disease Differential Diagnosis of PAS-Positive, Diastase-resistant Globules in Liver Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Alpha-1-antitrypsin bodies in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Intra- and extracellular alpha 1-antitrypsin in liver disease with special reference to Pi phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Hepatocytic globules in end-stage hepatic disease: relationship to alpha1-antitrypsin phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Hepatocarcinogenesis (Z#2)/mutagenesis during initiation stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Alpha-1-antitrypsin: an ignored protein in understanding liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Does the Z gene variant of alpha-1-antitrypsin predispose to hepatic carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Serine protease inhibitors in patients with chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Reactive biliary epithelium: the product of a pluripotential stem cell compartment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2668%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

10.1002/1097-0142(20000615)88:12<2668::AID-CNCR4>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference